Faruqi & Faruqi, LLP Encourages Investors in Ohr Pharmaceutical, Inc.’s Public Offerings To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, announces that it has been appointed as Lead Counsel in Khanna v. Ohr Pharmaceutical, Inc., et al., No. 1:18-cv-01284-LAP (S.D.N.Y.), a class action alleging violations of the federal securities laws against Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (NASDAQ:OHRP) and certain of the Company’s officers and directors.
If you purchased shares pursuant to Ohr’s public offerings on or about (1) April 8, 2014; (2) February 6, 2015; (3) December 8, 2016; and (4) April 5, 2017, and/or you purchased Ohr stock in the open market between April 8, 2014 and January 4, 2018, both dates inclusive, please contact the firm to discuss this matter with us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an email to email@example.com.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Ohr’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Request more information now by filling out the form below. There is no cost or obligation to you.
OHR Pharmaceutical, Inc. (OHRP
* The submission of this form does not create an attorney-client relationship.
Filed on 02/16/2018
685 Third Avenue 26th Floor
10017 New York, New York
Phone (212) 983-9330
Fax (212) 983-9331
Richard W. Gonnello firstname.lastname@example.org Phone (212) 983-9330 Fax (212) 983-9331